Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Independent investigators report efficacy of Eisai cephalosporin

Sep. 24, 1998

Meiji Seika profiles preclinical activity of new parenteral cephalosporin

Sep. 24, 1998

Collaborative work by Otsuka and Taiho leads to broad-spectrum, water-soluble cephems

Sep. 22, 1998

Bactericidal actions of plaunotol demonstrated

Sep. 22, 1998

Preparation and antibacterial activity of new cephems disclosed by Otsuka

Sep. 21, 1998

Meiji Seika's new macrolides active against Gram-positive microorganisms

Sep. 21, 1998

Famciclovir effectively suppresses recurrent genital herpes

Sep. 17, 1998

BioCryst licenses small-molecule neuraminidase inhibitors to J&J companies

Sep. 16, 1998

Wyeth-Lederle researchers discover potential treatment for RSV infection

Sep. 15, 1998

Siga identifies lead antibiotic compound

Sep. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 10, 2025.
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol
BioWorld
In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
Omada, Caris arrivals continue med-tech IPO hot streak
BioWorld MedTech
Omada Health Inc. rang the opening bell on the New York Stock Exchange on June 6, marking its first day as a public company, but it won’t be the most recent IPO...